Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Pak Med Assoc ; 66(3): 285-91, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26968278

RESUMEN

OBJECTIVE: To investigate the effects of collagen and growth factors on in vitro proliferation of human spermatogonial stem cells obtained from patients with non-obstructive azoospermia. METHODS: The experimental cross-sectional study was conducted from February 2013 to April 2015 after obtaining approval from the ethics committee of Ahvaz Jundishapur University of Medical Sciences, Iran. Testicular sperm extractions of non-obstructive azoospermic patients were obtained from the Clinical Urology and Embryology, In Vitro Fertilization Department of Imam Khomeini Hospital. Spermatogonial stem cells and Sertoli cells, obtained from human testis biopsies by a two-step enzymatic digestion method, were purified using fluorescence- activated cell-sorting and daturastramonium-lectin, and were cultured separately. To investigate a more direct influential factor on colony formation, one control and two experimental groups were formed. Group 1 acted as the control in which spermatogonial stem cells were co-cultured with Sertoli cells alone. In group 2 they were co-cultured with Sertoli cells and growth factors such as leukaemia inhibitory factor, epidermal growth factor and glial cell-derived neurotrophic factor, and in group 3 with Sertoli cells along with growth factors in the presence of collagen-coated dishes. Number and diameter of the colonies were evaluated after 7 weeks. RESULTS: Specimens obtained related to 21 patients. Number and diameter of the colonies in group 3 (18±2.6 and 276.6±45.5) were significantly more than both groups 1 (3.5±1 and D1:81.6±12) and group 2(11±2.2 and 165.2±32.5) (p<0.05 each). Also, the number and diameter of colony in group 2 were significantly better than the control group (p<0.05).Expression profile of the VASA, promyelocytic leukaemia zinc-finger (PLZF), Octamer-binding transcription factor 4 (OCT4) and integrin a6 (INTGa6) were detected in all groups. Based on cytochemical findings, OCT4 was expressed in the colonies of all three groups. CONCLUSIONS: According to positive effects of collagen and growth factors on the colonisation of spermatogonial stem cells, it seems that using the cells may lead to better colonisation of this type of stem cells.


Asunto(s)
Células Madre Germinales Adultas/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Colágeno/farmacología , Células Madre Germinales Adultas/citología , Azoospermia , Técnicas de Cultivo de Célula , Técnicas de Cocultivo , Estudios Transversales , ARN Helicasas DEAD-box/efectos de los fármacos , ARN Helicasas DEAD-box/metabolismo , Factor de Crecimiento Epidérmico/farmacología , Citometría de Flujo , Factor Neurotrófico Derivado de la Línea Celular Glial/farmacología , Humanos , Integrina alfa6/efectos de los fármacos , Integrina alfa6/metabolismo , Factores de Transcripción de Tipo Kruppel/efectos de los fármacos , Factores de Transcripción de Tipo Kruppel/metabolismo , Factor Inhibidor de Leucemia/farmacología , Masculino , Factor 3 de Transcripción de Unión a Octámeros/efectos de los fármacos , Factor 3 de Transcripción de Unión a Octámeros/metabolismo , Proteína de la Leucemia Promielocítica con Dedos de Zinc , Células de Sertoli
2.
Mol Cancer Ther ; 13(6): 1558-66, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24739392

RESUMEN

Laminin-binding integrin receptors are key mediators of epithelial cell migration and tumor metastasis. Recent studies have demonstrated a role for the α6 integrin (ITGA6/CD49f) in maintaining stem cell compartments within normal bone marrow and in residency of tumors metastatic to bone. In this study, we tested a function-blocking antibody specific for ITGA6, called J8H, to determine if preexisting cancer lesions in bone could be slowed and/or animal survival improved. Human prostate tumors were established by intracardiac injection into male SCID mice and treatment with J8H antibody was initiated after 1 week. Tumor progression was monitored by micro-computed tomography (CT) imaging of skeletal lesions. Animals that received weekly injections of the anti-ITGA6 antibody showed radiographic progression in only 40% of osseous tumors (femur or tibia), compared with control animals, where 80% of the lesions (femur or tibia) showed progression at 5 weeks. Kaplan-Meier survival analysis demonstrated a significant survival advantage for J8H-treated animals. Unexpectedly, CT image analysis revealed an increased proportion of bone lesions displaying a sclerotic rim of new bone formation, encapsulating the arrested lytic lesions in animals that received the anti-ITGA6 antibody treatment. Histopathology of the sclerotic lesions demonstrated well-circumscribed tumor within bone, surrounded by fibrosis. These data suggest that systemic targeting of the ITGA6-dependent function of established tumors in bone may offer a noncytotoxic approach to arrest the osteolytic progression of metastatic prostate cancer, thereby providing a new therapeutic strategy for advanced disease.


Asunto(s)
Anticuerpos Monoclonales de Origen Murino/administración & dosificación , Anticuerpos/administración & dosificación , Neoplasias Óseas/tratamiento farmacológico , Integrina alfa6/metabolismo , Terapia Molecular Dirigida , Neoplasias de la Próstata/tratamiento farmacológico , Animales , Neoplasias Óseas/patología , Neoplasias Óseas/secundario , Línea Celular Tumoral , Humanos , Integrina alfa6/efectos de los fármacos , Masculino , Ratones , Osteoblastos/patología , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología , Ensayos Antitumor por Modelo de Xenoinjerto
3.
J Periodontal Res ; 43(4): 386-90, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18221296

RESUMEN

BACKGROUND AND OBJECTIVE: Short-chain fatty acids, such as butyric acid, are detected in periodontal pockets and are thought to be involved in the initiation and progression of periodontal disease. In the present study, we examined the effects of butyric acid on adhesion molecule expression by human gingival epithelial cells. MATERIAL AND METHODS: The human gingival carcinoma cell line, Ca9-22, was cultured in media that contained different concentrations of butyric acid. RESULTS: Cell numbers were significantly decreased in a dose-dependent manner by butyric acid at concentrations of > or = 0.2 mM. The expression of intercellular adhesion molecule-1 mRNA was significantly increased 6 h after stimulation. By contrast, the expression levels of integrins alpha 6 and beta 4 were decreased. Similar results were obtained by flow cytometry. CONCLUSION: The results of the present study indicate that butyric acid alters the expression of adhesion molecules by Ca9-22 cells. The elucidation of the mechanism of action of butyric acid on the periodontium may help to clarify several aspects of the onset and progression of periodontal disease.


Asunto(s)
Ácido Butírico/farmacología , Moléculas de Adhesión Celular/efectos de los fármacos , Encía/efectos de los fármacos , Ácido Butírico/administración & dosificación , Recuento de Células , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Citometría de Flujo , Encía/patología , Humanos , Integrina alfa6/efectos de los fármacos , Integrina beta4/efectos de los fármacos , Molécula 1 de Adhesión Intercelular/efectos de los fármacos , Microscopía Electrónica de Rastreo , Reacción en Cadena de la Polimerasa , Factores de Tiempo
4.
J Leukoc Biol ; 77(2): 159-65, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15539457

RESUMEN

In vitro and in vivo evidence supports a functional role for the integrin alpha6beta1 in neutrophil migration through the perivascular basement membrane, a response that in vivo appears to be associated with platelet/endothelial cell adhesion molecule-1 (PECAM-1)-mediated up-regulation of alpha6beta1 on the cell surface of transmigrating leukocytes. As the involvement of PECAM-1 in leukocyte migration is cytokine-specific, the aim of the present study was to investigate whether alpha6beta1 exhibited a similar profile of stimulus specificity in this context. The cytokines interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) were used to elicit neutrophil migration in two murine models of inflammation, migration through cremasteric venules, as observed by intravital microscopy, and migration into the peritoneal cavity. The role of alpha6beta1 was investigated using an alpha6 integrin-blocking monoclonal antibody GoH3. In both models, GoH3 significantly inhibited neutrophil transmigration induced by IL-1beta but not TNF-alpha. This cytokine-specific role of alpha6 integrin was associated with enhanced cell-surface expression of alpha6beta1 on transmigrated neutrophils (as compared with blood cells) in response to IL-1beta but not TNF-alpha. Using lipopolysaccharide as an inflammatory stimulus in the cremaster muscle model, the study also provides evidence for the involvement of alpha6 integrin in leukocyte transmigration as mediated by endogenously generated IL-1beta. Collectively, the findings demonstrate that alpha6beta1 blockade inhibits neutrophil migration induced by exogenous and endogenous IL-1beta but not TNF-alpha, observations that are associated with increased expression of the integrin on transmigrated leukocytes.


Asunto(s)
Anticuerpos Monoclonales/farmacología , Integrina alfa6/efectos de los fármacos , Interleucina-1 , Infiltración Neutrófila/fisiología , Neutrófilos/fisiología , Factor de Necrosis Tumoral alfa , Animales , Integrina alfa6/biosíntesis , Integrina alfa6/fisiología , Integrina alfa6beta1/antagonistas & inhibidores , Integrina alfa6beta1/fisiología , Interleucina-1/antagonistas & inhibidores , Interleucina-1/farmacología , Leucocitos/efectos de los fármacos , Leucocitos/fisiología , Lipopolisacáridos/farmacología , Ratones , Ratones Endogámicos C57BL , Infiltración Neutrófila/efectos de los fármacos , Neutrófilos/efectos de los fármacos , Factor de Necrosis Tumoral alfa/farmacología
5.
J Trauma ; 57(1 Suppl): S13-21, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15280745

RESUMEN

BACKGROUND: Investigations were performed to determine whether poly-N-acetyl glucosamine (p-GlcNAc) induces hemostasis by the activation of platelets. METHODS: Platelets were isolated from human blood, fixed in the presence poly-N-acetyl glucosamine fibers, and visualized with scanning electron microscopy. Platelet activation surface markers were measured by fluorescence multiphoton microscopy. Platelet aggregation in the presence of p-GlcNAc fibers and integrin receptor blockers was measured. RESULTS: Scanning electron microscopy indicated that contact of platelets with poly-N-acetyl glucosamine fibers resulted in platelet activation. Fluorescent microscopy showed that contact of platelets with the marine polymer increased intracellular levels of free calcium and resulted in surface exposure of platelet phosphatidylserine, P selectin, and the alphaIIbbeta3 integrin. Antibody inhibitors of the platelet alphaIIbbeta3 integrin inhibited p-GlcNAc to stimulate fibrin polymerization. CONCLUSION: Poly-N-acetyl glucosamine fiber material promotes hemostasis by the activation of platelets.


Asunto(s)
Acetilglucosamina/farmacología , Plaquetas/efectos de los fármacos , Quitina/análogos & derivados , Hemostáticos/farmacología , Activación Plaquetaria/efectos de los fármacos , Acetilglucosamina/química , Plaquetas/ultraestructura , Calcio/fisiología , Quitina/química , Quitina/farmacología , Quitosano , Evaluación Preclínica de Medicamentos , Fibrina/efectos de los fármacos , Hemostasis Quirúrgica/métodos , Hemostáticos/química , Humanos , Integrina alfa2 , Integrina alfa5/efectos de los fármacos , Integrina alfa6/efectos de los fármacos , Integrina beta3/efectos de los fármacos , Líquido Intracelular/efectos de los fármacos , Glicoproteínas de Membrana/efectos de los fármacos , Microscopía Electrónica de Rastreo , Microscopía de Fluorescencia por Excitación Multifotónica , Selectina-P/efectos de los fármacos , Fosfatidilserinas/fisiología , Activación Plaquetaria/fisiología , Adhesividad Plaquetaria/efectos de los fármacos , Complejo GPIb-IX de Glicoproteína Plaquetaria/efectos de los fármacos , Glicoproteína IIb de Membrana Plaquetaria/efectos de los fármacos , Espectrofotometría , Factores de Tiempo
6.
Thromb Res ; 106(4-5): 213-21, 2002 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-12297128

RESUMEN

Fucoidans are sulfated polysaccharides extracted from brown marine algae. A purified fucoidan fraction exhibits the same venous antithrombotic activity as heparin in rabbits, but with a lower anticoagulant effect. Because of its heparin-like structure, we postulated that fucoidan might modulate heparin-binding angiogenic growth factor activity. We thus studied its effect, at antithrombotic concentrations, on fibroblast growth factor (FGF)-2-induced proliferation and differentiation of human umbilical vein endothelial cells. The fucoidan effect on endothelial cell differentiation was evaluated by studying the expression of surface proteins (i.e. integrin, adhesion molecule) known to be modulated by FGF-2 and involved in angiogenesis, and by quantifying closed areas delimited by vascular tubes formed on reconstituted basement membrane. Fucoidan had no modulatory effect on the mitogenic activity of FGF-2, but significantly increased tubular structure density induced by FGF-2. Fucoidan alone increased alpha(6) integrin subunit expression with only partially organized tubular structure. In the presence of FGF-2, fucoidan enhanced alpha(6), beta(1) and PECAM-1 and inhibited alpha(v)beta(3) integrin expression. Heparin had no effect in these systems. The most striking effect of fucoidan was observed on alpha(6) expression and tube formation was abolished by monoclonal anti-alpha(6) antibodies. Fucoidan plus FGF-2 effect on alpha(6) expression was markedly decreased by monoclonal anti-FGF-2 antibodies, indicating that fucoidan acts mainly via FGF-2. These results show that, at antithrombotic concentrations, contrary to heparin, fucoidan can enhance vascular tube formation induced by FGF-2 with a modulation of the expression of surface proteins (mainly alpha(6)) involved in angiogenesis.


Asunto(s)
Anticoagulantes/farmacología , Factor 2 de Crecimiento de Fibroblastos/fisiología , Neovascularización Fisiológica/efectos de los fármacos , Polisacáridos/farmacología , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Humanos , Integrina alfa6/análisis , Integrina alfa6/efectos de los fármacos , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/análisis , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/efectos de los fármacos , Venas Umbilicales/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...